Icecure Medical Stock Probability of Future Stock Price Finishing Under 0.6

ICCM Stock  USD 1.11  0.01  0.89%   
Icecure Medical's future price is the expected price of Icecure Medical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Icecure Medical performance during a given time horizon utilizing its historical volatility. Check out Icecure Medical Backtesting, Icecure Medical Valuation, Icecure Medical Correlation, Icecure Medical Hype Analysis, Icecure Medical Volatility, Icecure Medical History as well as Icecure Medical Performance.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
  
At this time, Icecure Medical's Price Book Value Ratio is very stable compared to the past year. As of the 25th of December 2024, Price To Book Ratio is likely to grow to 4.22, while Price Earnings Ratio is likely to drop (3.50). Please specify Icecure Medical's target price for which you would like Icecure Medical odds to be computed.

Icecure Medical Target Price Odds to finish below 0.6

The tendency of Icecure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.60  or more in 90 days
 1.11 90 days 0.60 
about 23.44
Based on a normal probability distribution, the odds of Icecure Medical to drop to $ 0.60  or more in 90 days from now is about 23.44 (This Icecure Medical probability density function shows the probability of Icecure Stock to fall within a particular range of prices over 90 days) . Probability of Icecure Medical price to stay between $ 0.60  and its current price of $1.11 at the end of the 90-day period is about 74.75 .
Given the investment horizon of 90 days Icecure Medical has a beta of -0.92. This usually indicates Moreover Icecure Medical has an alpha of 1.018, implying that it can generate a 1.02 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Icecure Medical Price Density   
       Price  

Predictive Modules for Icecure Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Icecure Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Icecure Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.106.96
Details
Intrinsic
Valuation
LowRealHigh
0.071.497.35
Details
3 Analysts
Consensus
LowTargetHigh
2.652.913.23
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.07-0.07-0.07
Details

Icecure Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Icecure Medical is not an exception. The market had few large corrections towards the Icecure Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Icecure Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Icecure Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.02
β
Beta against Dow Jones-0.92
σ
Overall volatility
0.18
Ir
Information ratio 0.16

Icecure Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Icecure Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Icecure Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Icecure Medical is way too risky over 90 days horizon
Icecure Medical may become a speculative penny stock
Icecure Medical appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.45 M.
Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Icecure Medical has a poor financial position based on the latest SEC disclosures
Roughly 54.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Data on IceCures ProSense Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North Americas 2024 Annual Meeting

Icecure Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Icecure Stock often depends not only on the future outlook of the current and potential Icecure Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Icecure Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding45.6 M
Cash And Short Term Investments11.1 M

Icecure Medical Technical Analysis

Icecure Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Icecure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Icecure Medical. In general, you should focus on analyzing Icecure Stock price patterns and their correlations with different microeconomic environments and drivers.

Icecure Medical Predictive Forecast Models

Icecure Medical's time-series forecasting models is one of many Icecure Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Icecure Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Icecure Medical

Checking the ongoing alerts about Icecure Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Icecure Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Icecure Medical is way too risky over 90 days horizon
Icecure Medical may become a speculative penny stock
Icecure Medical appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.45 M.
Icecure Medical currently holds about 17.73 M in cash with (12.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48.
Icecure Medical has a poor financial position based on the latest SEC disclosures
Roughly 54.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Data on IceCures ProSense Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North Americas 2024 Annual Meeting
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.071
Quarterly Revenue Growth
0.079
Return On Assets
(0.47)
Return On Equity
(0.94)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.